丁苯酞注射液联合依达拉奉治疗急性脑梗死的效果评价

Effect of Butylphthalide Injection and Edaravone in Treatment of Acute Cerebral Infarction

目的研究丁苯酞注射液+依达拉奉对急性脑梗死患者的治疗价值。方法选取2015年5月—2017年5月本院急性脑梗死患者30例,随机分为2组,各15例。对照组给予依达拉奉,观察组在对照组的基础上联合使用丁苯酞注射液,对比2组不同时间段的NIHSS评分结果。结果观察组治疗7天和治疗14天的NIHSS分值与对照组对比,P<0.05。结论依达拉奉联合丁苯酞注射液治疗急性脑梗死效果理想。

Objective To study the therapeutic value of butylphthalide injection and edaravone in the treatment of acute cerebral infarction. Methods From May 2015 to May 2017, 30 patients with acute cerebral infarction were divided into 2 groups according to the principle of remote randomization, and 15 cases in each group. The control group was given edaravone, and the observation group was combined with butylphthalide injection on the basis of the control group, and the results of the NIHSS score of the 2 groups at diferent time periods were compared. Results The NIHSS scores of the observation group for 7 days and the 14 days treatment were compared with the control group, P〈0.05. Conclusion Edaravone combined with butylphthalide injection is ideal for the treatment of acute cerebral infarction.